ASCO 2016 | Somatic genomic landscape of advanced-stage cancer patients from clinical NGS analysis of ctDNA

Philip Mack

Press brief by Philip Mack, PhD of the UC Davis Comprehensive Cancer Center, Sacramento, CA, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Share this video  
Similar topics
Related videos
0:56
MOUNTAINEER results: trastuzumab and tucatinib for HER2+ mCRC
John Strickler
3:15
Kidney cancer: post-surgery sorafenib
Tim Eisen
1:06
Melanoma news from ESMO 19
Georgina Long
2:31
IDEA-FRANCE: ctDNA as a predictive value for adjuvant treatment duration
Thierry André
1:25
PARP inhibitors for ovarian cancer - room for improvement with HRD testing
Thomas Helleday
Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer, Genitourinary Cancer, Gynecological Cancer, Gynecological Cancer, Lung Cancer, Skin Cancer
ASCO 2016
Press Brief
3rd June 2016
vjoncology logo VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals